Women & Sex Differences Research Group

What We Do

The mission of the Women and Sex Differences Research Program is to 1) promote careers of women scientists and 2) promote the conduct, translation and dissemination of research on:

  • Sex differences in the pharmacology, neurobiology, behavioral and socioeconomic determinants of substance use disorders (SUD), and responses to substances of abuse.
  • Interactions of SUD risk factors, SUD and substances of abuse with changes in female physiology and behavior across the lifespan.
  • Prevention and health services that maximizes the efficient delivery of high-quality, personalized addiction treatment and related services to women across the lifespan.  

Objectives [or Priorities]

  • Develop NIDA’s Women’s and Sex Differences Research Agenda that will advance the science on the causes and consequences of drug use and addiction among women across the lifespan and highlight sex differences.
  • Cultivate and strengthen partnerships within NIDA, NIH-wide and beyond.
  • Provide an opportunity for early career investigators to present their research, career development experience, and share lessons learned and thoughts on what’s needed to advance the science in the field.

Funding Opportunities & Announcements

Selected Funding Announcements in which NIDA participates.

“NIDA is a collaborative partner on the NIH Coordinating Committee for Maternal Morbidity and Mortality (CCM3) which is an NIH-wide committee that coordinates the  Implementing a Maternal health and Pregnancy Outcomes Vision for Everyone (IMPROVE) initiative. The IMPROVE initiative advances maternal mortality, maternal morbidity and health disparities research to reduce pregnancy-related deaths and complications in the United States.” See press release on the recently funded Maternal Health Research Centers of Excellence.

Training and Career Development Opportunities

Resources of Interest

Related Workgroups

  • Coordinating Committee for Maternal Morbidity and Mortality (CCM3)” (contact Keisher Highsmith)
  • CCRWH Working group on Understanding Complex Morbidity (contact Holly Moore)
  • CCRWH Working group on Reproductive Transitions (contact NIHCCRWH)
  • Maternal Mortality Task Force
  • CCRWH Covid-19 Working group

Other Web Sites of Interest